CMS Medicare CBD Coverage April 2026: What It Means for Cannabis Investors

By Sheeba M. | April 02, 2026 CMS Medicare CBD Coverage April 2026: What It Means for Cannabis Investors TL;DR: A CMS Innovation Center pilot launching in April 2026 will allow Medicare to cover up to $500 annually for hemp-derived CBD products for qualifying beneficiaries — potentially unlocking a new revenue channel for CBD brands […]

Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026

By Sheeba M. | April 02, 2026 Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026 TL;DR: German cannabis reform unlocks €15B market opportunity as Canadian LPs face intensifying local competition. Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026 TL;DR: Canada’s largest cannabis companies dominated European market entry, but shifting […]

Delta-8 THC Regulatory Landscape: What Cannabis Investors Need to Know in 2026

By Sheeba M. | April 02, 2026 Delta-8 THC Regulatory Landscape: What Cannabis Investors Need to Know in 2026 TL;DR: Delta-8 THC regulatory landscape creates opportunity for compliant operators. Delta-8 THC Regulatory Landscape: What Cannabis Investors Need to Know in 2026 TL;DR: Delta-8 THC sits in a regulatory gray zone that creates both risk and […]

CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads

By Sheeba M. | April 02, 2026 CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads TL;DR: CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads The Cannabidiol (CBD) market is projected to grow substantially through 2034, according to a new analysis from ResearchAndMarkets, … CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads The […]

Canopy Growth Deelish: Canada’s Cannabis Value Segment Just Got More Competitive

By Sheeba M. | April 02, 2026 Canopy Growth Deelish: Canada’s Cannabis Value Segment Just Got More Competitive TL;DR: Canopy Growth Deelish: Canada’s Cannabis Value Segment Just Got More Competitive Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) launched Deelish, a new cannabis brand targeting the value segme… Canopy Growth Deelish: Canada’s Cannabis Value Segment Just […]

CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads

By Sheeba M. | April 01, 2026 CBD Market Forecast to 2034: Industry Faces Regulatory Crossroads TL;DR: The global CBD market is projected to grow at mid-teens CAGR through 2034, driven by health and wellness trends, but U.S. regulatory uncertainty — particularly around FDA guidance — remains the key risk factor for industry growth. The […]

Canopy Growth Deelish: Canada Value Segment Strategy

By Sheeba M. | April 01, 2026 Canopy Growth Deelish: Canada Value Segment Strategy TL;DR: Canopy Growth’s new Deelish budget brand targets Canada’s value-conscious cannabis consumers with sub-$6/g pricing — a strategic move to reclaim market share lost to illicit operators. Canopy Growth Deelish: Canada’s Cannabis Value Segment Just Got More Competitive Canopy Growth Corporation […]

Multi-State Operators Outperform as Regional Brands Struggle

By Sheeba M. | April 01, 2026 Multi-State Operators Outperform as Regional Brands Struggle TL;DR: Multi-state cannabis operators like GTI and CURLF are gaining market share and improving unit economics, while smaller regional brands face margin compression and inventory overhang. By Sheeba M. | April 1, 2026 Multi-State Operators Outperform as Regional Brands Struggle TL;DR: […]

Cannabis Stocks Rally as Senate Banking Reform Gains Momentum

By Sheeba M. | April 01, 2026 Cannabis Stocks Rally as Senate Banking Reform Gains Momentum TL;DR: Cannabis stocks surged this week as the SAFE Banking Act advanced in the Senate — Wall Street is pricing in federal cannabis reform as a near-term probability. By Sheeba M. | April 1, 2026 Cannabis Stocks Rally as […]

📅 Yesterday's News & Older Articles →